NASDAQ:BNR

Burning Rock Biotech Q3 2026 Earnings Date & Estimates

Burning Rock Biotech logo
$13.27 -0.05 (-0.38%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$13.28 +0.02 (+0.11%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Burning Rock Biotech is estimated to report Q3 2026 earnings on Monday, November 23, 2026. The conference call is scheduled for November 27, 2026 at 12:30 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Conference Call Date
Conference Call
12:30 PM ET

What Analysts Expect from Burning Rock Biotech in Q3 2026

Burning Rock Biotech is expected to post earnings of -$0.3412 per share on revenue of $19.20 million. Burning Rock Biotech last reported on September 10, 2026, posting -$0.20 per share and beating the -$2.2883 consensus estimate.

Consensus Estimates

Consensus EPS
-$0.3412
Expected Revenue
$19.20 million

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.20 (Beat by +$2.0883)
Last Quarter Revenue
$19.84 million

Burning Rock Biotech Q3 2026 Earnings FAQ

Burning Rock Biotech (NASDAQ:BNR) is estimated to report Q3 2026 earnings on Monday, November 23, 2026. This date is estimated from past reporting schedules and may change once the company confirms it.

Burning Rock Biotech's Q3 2026 earnings conference call is scheduled for Friday, November 27, 2026 at 12:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Burning Rock Biotech to post earnings of -$0.3412 per share for Q3 2026.

The consensus revenue estimate for Burning Rock Biotech is $19.20 million for Q3 2026.

Burning Rock Biotech Earnings Headlines

Burning Rock Biotech (BNR) versus Its Competitors Critical Analysis
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
Burning Rock Biotech (BNR) Projected to Release Earnings on Tuesday
See More Burning Rock Biotech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Burning Rock Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Burning Rock Biotech and other key companies, straight to your email.

About Burning Rock Biotech

Burning Rock Biotech (NASDAQ:BNR) is a precision oncology company that develops and provides next-generation sequencing tests for cancer. Its testing uses tissue and blood samples to help inform treatment decisions, monitor disease and support cancer research.

The company also provides research and clinical-trial services to pharmaceutical companies, including support for the development of cancer therapies and diagnostic tests. Burning Rock is headquartered in Guangzhou, China, and its business primarily serves the Chinese healthcare and life sciences markets.

Founded in 2014, Burning Rock focuses on applying genomic testing to cancer care, including the development of tests for treatment selection and disease monitoring.

View Burning Rock Biotech Profile